Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma

Vaccine

Volumn 24, Issue 44-46, 2006, Pages 6620-6623

  Brydak, Lidia B ^a,b   Machała, Magdalena ^a   Centkowski, Piotr ^c   Warzocha, Krzysztof ^c   Biliński, Przemysław ^c  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMAGGLUTINATION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHODGKIN LYMPHOMA; NOSE SMEAR; PRIORITY JOURNAL; THROAT CULTURE; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, ACTIVE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; VACCINATION;

EID: 33846242197     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.100     Document Type: Article

References (21)

1. Brydak LB, Influenza and its prophylaxis. Poznan 2003, Wydawnictwo Termedia, 2nd ed., p. 1-272 [in Polish].
2. Centers for Disease Control and Prevention. WHO collaborating center for the surveillance, epidemiology and control of influenza. The 2004-2005 WHO influenza reagent kit for identification of influenza isolates. Atlanta; 2004. p. 1-23.
3. Nichol K.L. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21 16 (2003) 1769-1775
4. Monto A.S., Hornbuckle K., and Ohmit S.E. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am. J. Epidemiol. 154 (2001) 155-160
5. Brydak L.B., and Machała M. Vaccinate yourself against influenza to avoid tragedy that happened to our grandparents. Information broschure for physicians (2005), Warsaw Voice, Warsaw ISBN 83-917744-5-7 [in Polish]
6. Brydak L.B., and Machała M. Humoral immune reposnse to influenza vaccination in patients from high risk groups. Drugs 60 1 (2000) 35-53 [in Polish]
7. Siriwardena A.N., Rashid A., Johnson M.R.D., and Dewey M.E. Cluster randomised controlled tiral of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care. Br. J. Gen. Pract. 52 (2002) 735-740
8. Centers for Disease Control and Prevention. WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza. Concepts and procedures for laboratory-based influenza surveillance (1982), U.S. Department of Health and Human Services, Public Health Service
9. Manuguerra J.-C., and Hannoun C. Influenza and other viral respiratory diseases. Surveillance and laboratory diagnosis (1999), Institut Pasteur, Paris p. 1-286
10. Glathe H., and Lange W. Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents. Drugs Aging 6 5 (1995) 368-387
11. Davis J.R., and Grillis E.A. Natural or vaccine-induced immunity as a predictor of immunity in the face of natural challenge with influenza virus. Epidemiol. Inf. 102 (1989) 325-333
12. Brydak L.B., Rokicka-Milewska R., Machała M., Jackowska T., and Sikorska-Fic B. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatr. Infect. Dis. J. 17 (1998) 125-129
13. Brydak L.B., Rajkowski T., Machała M., We{ogonek}glarska J., and Sieniawska M. Humoral antibody response following influenza vaccination in patients with nephrotic syndrome. Antiinfect. Drugs Chemother. 16 2 (1998) 151-155
14. Brydak L.B., Rokicka-Milewska R., Machała M., Klukowska A., Łaguna P., and Sikorska-Fic B. Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia. Clin. Microbiol. Infect. 4 (1998) 589-593
15. Brydak L.B., Roszkowska-Blaim M., Machała M., Leszczyńska B., and Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 18 (2000) 3280-3286
16. Brydak L.B., Guzy J., Starzyk J., Machała M., and Góźdź S. Humoral immune response after vaccination against influenza in patients with breast cancer. Support. Care Cancer 9 (2001) 65-68
17. Brydak L.B., Roszkowska-Blaim M., Machała M., Leszczyńska B., and Sieniawska M. Immunological response to influenza vaccination in children with renal failure. Nephrol. Dial. Transpl. 16 3 (2001) 643-644
18. Brydak L.B., Machała M., Myśliwska J., Myśliwski A., and Trzonkowski P. Immune response to influenza vaccination in an elderly population. J. Clin. Immunol. 23 3 (2003) 214-222
19. Rokicka-Milewska R., Brydak L.B., Machała M., and Klukowska A. Antibody response to influenza vaccine in children with severe and mild hemophila. Int. J. Pediatr. Hematol./Oncol. 7 1 (2000) 21-27
20. Committee for Proprietary Medicinal Products (CPMP): note for guidance on harmonisation of requirements for influenza vaccines. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit (EMEA). CPMP/BWP/214/96, London, March 12, 1997.
21. Ada G.L. Immune response. General features. In: Granoff A., and Webster R.G. (Eds). Encyclopedia of virology. 2nd ed. vol. 2 (1999), Academic Press 812-818